Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tregs”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Testing effectiveness (Phase 2)Looking for participantsNCT06552169
What this trial is testing

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Who this might be right for
Kidney Transplantation
Singulera Therapeutics Inc. 34
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Early research (Phase 1)Looking for participantsNCT06708780
What this trial is testing

Immunotherapy with Autologous Tregs in T1DM

Who this might be right for
Type 1 Diabetes Mellitus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Early research (Phase 1)Study completedNCT00675831
What this trial is testing

Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dana-Farber Cancer Institute 24
Not applicableStudy completedNCT03249064
What this trial is testing

Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

Who this might be right for
VITILIGO
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 28
Very early researchNot Yet RecruitingNCT07395050
What this trial is testing

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Who this might be right for
Stage 3 Type 1 Diabetes
City of Hope Medical Center 6
Not applicableStudy completedNCT03891485
What this trial is testing

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy

Who this might be right for
RCCMetastatic Renal Cell Carcinoma
National Cancer Institute, Naples 200
Testing effectiveness (Phase 2)Study completedNCT02424396
What this trial is testing

Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Early research (Phase 1)Study completedNCT02088931
What this trial is testing

Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation

Who this might be right for
Late Complication From Kidney Transplant
University of California, San Francisco 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499102
What this trial is testing

CK0801 for Treatment of Aplastic Anemia

Who this might be right for
Aplastic Anemia
Cellenkos, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06697197
What this trial is testing

BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 413
Early research (Phase 1)Ended earlyNCT02188719
What this trial is testing

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

Who this might be right for
Liver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)UnknownNCT00703105
What this trial is testing

Ovarian Dendritic Cell Vaccine Trial

Who this might be right for
Ovarian Cancer
Loyola University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07697118
What this trial is testing

Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like.

Who this might be right for
The Immune Dysregulation Polyendocrinopathy Enteropathy X-linked Syndrome is a Primary Immunodeficiency Caused by Pathogenic Variants in Forkhead Box Protein 3
Assistance Publique - Hôpitaux de Paris 5
Not applicableLooking for participantsNCT07744373
What this trial is testing

Tregs and miRNAs in Breast Milk: Effects on Infant Food Tolerance

Who this might be right for
Immune ToleranceFood Tolerance
Istanbul University 25
Not applicableStudy completedNCT02317133
What this trial is testing

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

Who this might be right for
Henoch Schönlein Purpura
Centre Hospitalier Universitaire de Nīmes 100
Not applicableNot Yet RecruitingNCT07171307
What this trial is testing

Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy

Who this might be right for
Conjunctivitis, Allergic
Instituto de Oftalmología Fundación Conde de Valenciana 60
Testing effectiveness (Phase 2)Study completedNCT04433585
What this trial is testing

LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Nektar Therapeutics 291
Post-approval studies (Phase 4)Study completedNCT04472481
What this trial is testing

Vitamin D Effect in Rheumatoid Arthritis.

Who this might be right for
Active Rheumatoid Arthritis
Tanta University 20
Next Page